Eagle’s Eye View: NOAC vs. Warfarin For AFib, Sex Disparities in Medical-Guided Therapy Among HFrEF Patients, Polygenic Risk in Families With Spontaneous SCAD
In this week’s View, Dr. Eagle discusses the use of non–Vitamin-K antagonist oral anticoagulants versus warfarin across the spectrum of body mass index and weight. He then explores sex disparities in longitudinal use and intensification of guideline-directed medical therapy among patients with newly diagnosed heart failure with reduced ejection fraction. Finally, Dr. Eagle talks about polygenic risk in families with spontaneous coronary artery dissection.
X Links:
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Heart Failure and Cardiomyopathies, Anticoagulation Management and Atrial Fibrillation, Atrial Fibrillation/Supraventricular Arrhythmias, Acute Heart Failure, Acute Coronary Syndromes, Pericardial Disease, Prevention, Vascular Medicine
Keywords: EaglesEyeView, Anticoagulants, Atrial Fibrillation, Body Weight, Guideline Adherence, Heart Failure, Sex Characteristics, Dissection, Genetic Variation, Heart Disease Risk Factors
< Back to Listings
